Search filters

List of works by Michele Morari

6-hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

scientific article published on 28 May 2020

Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice

scientific article published on 14 March 2017

Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists.

scientific article published on 12 December 2017

G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice

scientific article published on 30 August 2018

Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.

scientific article published on 21 January 2016

Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia.

scientific article published on 29 October 2015

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates

scientific article published on 13 May 2020

Leucine‐rich repeat kinase 2 ( LRRK 2) inhibitors differentially modulate glutamate release and Serine935 LRRK 2 phosphorylation in striatal and cerebrocortical synaptosomes

scientific article published on 27 May 2019

Managing Parkinson's disease: moving ON with NOP

scientific article published on 03 January 2020

Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for <scp>l</scp>‐Dopa‐induced dyskinesia

scientific article published on 12 January 2022

Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia

scientific article published on 22 November 2017

Paulina is supported by:

About Paulina

Help